Abstract

The aim of the study was to investigate the effect of the carbon monoxide (CO) donor on the Ca 2+ -activated potassium permeability of the erythrocyte membrane and platelet aggregation ability. Materials and methods. Healthy volunteers ( n = 27) and patients with chronic coronary heart disease (CHD) ( n = 32) of both sexes were examined. The material of the study was packed red blood cells and platelet-rich plasma obtained from patient’s venous blood. The change of Ca 2+ -dependent potassium conductivity of the erythrocyte membrane was evaluated by potentiometric method, and the platelet aggregation was studied by turbidimetric method. Carbon monoxide releasing molecule-2 ( CORM-2) was used as a CO donor. The amplitude of A23187- and redox-induced hyperpolarization response (HR) of erythrocytes, and the rate and degree of platelet aggregation were estimated. Results. It was shown that the addition of CORM-2 (10 and 100 μM) in the erythrocyte suspension caused a dose-dependent decrease in the amplitude of A23187- and redox-dependent HR in healthy donors, as well as in patients with chronic CHD. The maximum decrease was observed in the presence of 100 μM CORM-2. The effect of CORM-2 at concentrations of 10 and 100 μM on collagen-induced platelet aggregation led to a decrease in the degree and rate of aggregation in healthy donors. The maximum effect was shown at 100 μM of CO donor. However, such an unambiguous effect of CORM-2 on the aggregation parameters in patients with CHD was not observed. Conclusion . The results suggest that CO has a significant effect on the ion transport function of the erythrocyte membrane and platelet aggregation activity of both healthy donors and patients with CHD.

Highlights

  • The aim of the study was to investigate the effect of the carbon monoxide (CO) donor on the Ca2+-activated potassium permeability of the erythrocyte membrane and platelet aggregation ability

  • The change of Ca2+-dependent potassium conductivity of the erythrocyte membrane was evaluated by potentiometric method, and the platelet aggregation was studied by turbidimetric method

  • It was shown that the addition of Carbon monoxide releasing molecule-2 (CORM-2) (10 and 100 μM) in the erythrocyte suspension caused a dose-dependent decrease in the amplitude of A23187- and redox-dependent hyperpolarization response (HR) in healthy donors, as well as in patients with chronic coronary heart disease (CHD)

Read more

Summary

ОРИГИНАЛЬНЫЕ СТАТЬИ

Цель исследования – изучить влияние донора монооксида углерода (СО) на Са2+-зависимую калиевую проницаемость мембраны эритроцитов и агрегационную способность тромбоцитов. Потенциометрическим методом изучали изменение Са2+-зависимой калиевой проводимости мембраны эритроцитов, турбидиметрическим методом – агрегационную активность тромбоцитов при действии донора СО (CORM-2). В присутствии 10 и 100 мкМ CORM-2 амплитуда А23187- и редокс-зависимого ГО здоровых доноров, как и пациентов с хронической формой ИБС, дозозависимо уменьшалась, причем максимальное снижение отмечено в присутствии 100 мкМ донора СО. Воздействие CORM2 в концентрациях 10 и 100 мкМ на коллаген-индуцированную агрегацию тромбоцитов приводило к снижению степени и скорости агрегации у здоровых доноров, достигая максимального эффекта при 100 мкМ донора СО. Полученные результаты указывают, что СО оказывает существенное влияние на ион-транспортную функцию мембраны эритроцитов и агрегационную активность тромбоцитов как здоровых доноров, так и пациентов с ИБС. Исследование одобрено локальным этическим комитетом СибГМУ (протокол No 4340 от 30.11.2015)

Оригинальные статьи
Экспериментальная оценка влияния экзогенного монооксида углерода
МАТЕРИАЛЫ И МЕТОДЫ
Вклад авторов
Сведения об авторах
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call